Prozkoumejte nejčtenější články a videa na Campus Sanofi
Expert consensus on monitoring individuals with T1D islet autoantibodies: detection, monitoring frequency, and psychosocial support for managing autoimmune T1D.
Screening for autoimmune T1D involves testing for autoantibodies that are markers of destruction of insulin-producing beta cells.
Type 1 diabetes is underpinned by autoimmune activity against insulin-producing beta cells, as explained in this video.
T1D is an autoimmune disease whereby autoreactive T-cells drive progressive beta-cell damage and destruction, ultimately leading to insulin deficiency, dysglycemia, and hyperglycemia.
Monitoring people with early-stage autoimmune T1D may reduce the risk of serious complications, such as DKA.
A brief overview of the tools available for monitoring people with presymptomatic autoimmune type 1 diabetes, and the pros and cons for each method.
The burden associated with a diagnosis of autoimmune T1D can be wide-ranging. This video describes the impact of diagnosis on an individual and their family.
Learn about the psychosocial impacts of type 1 diabetes and explore expert guidance on how to integrate psychosocial care into routine care.